These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

294 related items for PubMed ID: 10534542

  • 1. Complement activation in patients with systemic lupus erythematosus without nephritis.
    Mollnes TE, Haga HJ, Brun JG, Nielsen EW, Sjöholm A, Sturfeldt G, Mårtensson U, Bergh K, Rekvig OP.
    Rheumatology (Oxford); 1999 Oct; 38(10):933-40. PubMed ID: 10534542
    [Abstract] [Full Text] [Related]

  • 2. Usefulness of detection of complement activation products in evaluating SLE activity.
    Nagy G, Brózik M, Varga L, Füst G, Kirschfink M, Kiss E, Gergely P.
    Lupus; 2000 Oct; 9(1):19-25. PubMed ID: 10713643
    [Abstract] [Full Text] [Related]

  • 3. High-dose intravenous immunoglobulin treatment activates complement in vivo.
    Mollnes TE, Høgåsen K, De Carolis C, Vaquero E, Nielsen EW, Fontana L, Perricone R.
    Scand J Immunol; 1998 Sep; 48(3):312-7. PubMed ID: 9743219
    [Abstract] [Full Text] [Related]

  • 4. SC5b-9 is the most sensitive marker in assessing disease activity in Brazilian SLE patients.
    Chiu YY, Nisihara RM, Würzner R, Kirschfink M, de Messias-Reason IJ.
    J Investig Allergol Clin Immunol; 1998 Sep; 8(4):239-44. PubMed ID: 9777539
    [Abstract] [Full Text] [Related]

  • 5. Sensitivity and specificity of plasma and urine complement split products as indicators of lupus disease activity.
    Manzi S, Rairie JE, Carpenter AB, Kelly RH, Jagarlapudi SP, Sereika SM, Medsger TA, Ramsey-Goldman R.
    Arthritis Rheum; 1996 Jul; 39(7):1178-88. PubMed ID: 8670328
    [Abstract] [Full Text] [Related]

  • 6. Activation of the alternative complement pathway accompanies disease flares in systemic lupus erythematosus during pregnancy.
    Buyon JP, Tamerius J, Ordorica S, Young B, Abramson SB.
    Arthritis Rheum; 1992 Jan; 35(1):55-61. PubMed ID: 1731815
    [Abstract] [Full Text] [Related]

  • 7. Assessment of disease activity and impending flare in patients with systemic lupus erythematosus. Comparison of the use of complement split products and conventional measurements of complement.
    Buyon JP, Tamerius J, Belmont HM, Abramson SB.
    Arthritis Rheum; 1992 Sep; 35(9):1028-37. PubMed ID: 1418018
    [Abstract] [Full Text] [Related]

  • 8. Nonrenal and renal activity of systemic lupus erythematosus: a comparison of two anti-C1q and five anti-dsDNA assays and complement C3 and C4.
    Julkunen H, Ekblom-Kullberg S, Miettinen A.
    Rheumatol Int; 2012 Aug; 32(8):2445-51. PubMed ID: 21706294
    [Abstract] [Full Text] [Related]

  • 9. Complement Alternative Pathway׳s Activation in Patients With Lupus Nephritis.
    Song D, Guo WY, Wang FM, Li YZ, Song Y, Yu F, Zhao MH.
    Am J Med Sci; 2017 Mar; 353(3):247-257. PubMed ID: 28262211
    [Abstract] [Full Text] [Related]

  • 10. Anti-C1q antibodies and antiendothelial cell antibodies in systemic lupus erythematosus - relationship with disease activity and renal involvement.
    Oelzner P, Deliyska B, Fünfstück R, Hein G, Herrmann D, Stein G.
    Clin Rheumatol; 2003 Oct; 22(4-5):271-8. PubMed ID: 14576989
    [Abstract] [Full Text] [Related]

  • 11. Relationship of Circulating Anti-C3b and Anti-C1q IgG to Lupus Nephritis and Its Flare.
    Birmingham DJ, Bitter JE, Ndukwe EG, Dials S, Gullo TR, Conroy S, Nagaraja HN, Rovin BH, Hebert LA.
    Clin J Am Soc Nephrol; 2016 Jan 07; 11(1):47-53. PubMed ID: 26700439
    [Abstract] [Full Text] [Related]

  • 12. Association of Blood Concentrations of Complement Split Product iC3b and Serum C3 With Systemic Lupus Erythematosus Disease Activity.
    Kim AHJ, Strand V, Sen DP, Fu Q, Mathis NL, Schmidt MJ, Bruchas RR, Staten NR, Olson PK, Stiening CM, Atkinson JP.
    Arthritis Rheumatol; 2019 Mar 07; 71(3):420-430. PubMed ID: 30294950
    [Abstract] [Full Text] [Related]

  • 13. Synovial fluid levels of complement SC5b-9 and fragment Bb are elevated in patients with rheumatoid arthritis.
    Brodeur JP, Ruddy S, Schwartz LB, Moxley G.
    Arthritis Rheum; 1991 Dec 07; 34(12):1531-7. PubMed ID: 1747138
    [Abstract] [Full Text] [Related]

  • 14. Prospective analysis of C1 dissociation and complement activation in patients with systemic lupus erythematosus.
    Jonsson H, Sturfelt G, Mårtensson U, Truedsson L, Sjöholm AG.
    Clin Exp Rheumatol; 1995 Dec 07; 13(5):573-80. PubMed ID: 8575134
    [Abstract] [Full Text] [Related]

  • 15. Complement fragment C4d and Bb levels in inflammatory skin diseases (e.g. SLE, atopic dermatitis, erythroderma and pustulosis palmaris et plantaris) for assessment of complement activation.
    Takematsu H, Tagami H.
    Tohoku J Exp Med; 1991 Apr 07; 163(4):263-8. PubMed ID: 1831937
    [Abstract] [Full Text] [Related]

  • 16. Routine immunologic tests in systemic lupus erythematosus: is there a need for more studies?
    Esdaile JM, Joseph L, Abrahamowicz M, Li Y, Danoff D, Clarke AE.
    J Rheumatol; 1996 Nov 07; 23(11):1891-6. PubMed ID: 8923362
    [Abstract] [Full Text] [Related]

  • 17. Correlation of the activation of the fourth component of complement (C4) with disease activity in systemic lupus erythematosus.
    Senaldi G, Makinde VA, Vergani D, Isenberg DA.
    Ann Rheum Dis; 1988 Nov 07; 47(11):913-7. PubMed ID: 3264693
    [Abstract] [Full Text] [Related]

  • 18. The value of complement measurements in the assessment of lupus activity.
    Milis L, Timmermans V, Morris CA, Pussell BA, Charlesworth JA.
    Aust N Z J Med; 1992 Aug 07; 22(4):338-44. PubMed ID: 1445021
    [Abstract] [Full Text] [Related]

  • 19. The value of complement activation products in the assessment of systemic lupus erythematosus flares.
    Porcel JM, Ordi J, Castro-Salomo A, Vilardell M, Rodrigo MJ, Gene T, Warburton F, Kraus M, Vergani D.
    Clin Immunol Immunopathol; 1995 Mar 07; 74(3):283-8. PubMed ID: 7859418
    [Abstract] [Full Text] [Related]

  • 20. Complement activating cryoglobulins in the nephritis of systemic lupus erythematosus.
    Adu D, Williams DG.
    Clin Exp Immunol; 1984 Mar 07; 55(3):495-501. PubMed ID: 6705265
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.